Alphabet Inc. (NASDAQ:GOOGL) is one of the unstoppable AI stocks to buy now. On May 12, Google announced the Googlebook, a new category of laptops built on an intelligence-focused system that integrates the Android tech stack with the ChromeOS browser experience The
Oklo Inc. (NYSE:OKLO) is one of the unstoppable AI stocks to buy now. On May 12, Oklo announced a Strategic Partnership Project with Idaho National Laboratory/INL to use the Prometheus AI platform for accelerating advanced reactor and fuel-system designs This collab
Applied Materials Inc. (NASDAQ:AMAT) is one of the unstoppable AI stocks to buy now. On May 3, Applied Materials entered into a definitive agreement to acquire the NEXX business from ASMPT Limited to expand its portfolio of panel-level advanced packaging technologies <
Vertiv Holdings Co. (NYSE:VRT) is one of the unstoppable AI stocks to buy now. On May 5, Vertiv appointed Frieda He as Chief Procurement Officer to lead its global procurement organization In this role, she will focus on strengthening supply chain resilience, optimi
Texas Roadhouse has raised menu prices amid inflation, prompting questions about whether other restaurants will do the same. Menu prices have begun to rise — modestly, according to a May 12 Restaurants increased prices by 0.2% in April for the second consecutive mon
Sunrise Realty Trust generates $0.35 per share in Q1 2026 Sunrise Realty Trust reported distributable earnings of $0.35 per share for the quarter ended March 31, 2026. The company's results were positively impacted, covering the dividend of $0.30 per share. The t
The aerospace firm cites strong organic growth in commercial and business aviation markets for its revenue guidance. Innovative Aerosystems projected third-quarter revenue of $24M to $26M, reflecting continued momentum in its core markets. The company highlighted organic g
ServiceNow reported 19% year-over-year subscription revenue growth and raised full-year guidance but saw shares decline on AI-driven growth concerns. ServiceNow shares dropped after first-quarter results despite beating top- and bottom-line expectations. The company report
Analysts expect ARS Pharmaceuticals to report a $0.54 loss per share and $22.12M revenue for Q1 2026. ARS Pharmaceuticals (SPRY) will release Q1 2026 earnings on May 15 before the market opens. The consensus estimate projects a loss of $0.54 per share, reflecting a 54.3% y
Euro slides as resilient US sales fuel Dollar rally EUR/USD edges lower for the third consecutive day during the North American session, down 0.22%, as US economic data showed consumers' resilience. In contrast, jobless benefits data showed a slight increase in the number
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.